Inversion and deletion of 16q22 defined by array CGH, FISH, and RT-PCR in a patient with AML

Cancer Genetics

Volumn 204, Issue 6, 2011, Pages 344-347

  Dawson, Angelika J ^a,b   Bal, Shibani ^a   McTavish, Barry ^a   Tomiuk, Michelle ^a   Schroedter, Ingo ^a   Ahsanuddin, Arshad N ^a,b   Seftel, Matthew D ^b   Vallente, Rhea ^c   Mai, Sabine ^b,c   Cotter, Philip D ^d   Hovanes, Karine ^d   Gorre, Mercedes ^d   Gunn, Shelly R ^d  

^a HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Genomic Centre for Cancer Research and Diagnostics   (Canada)

^d CombiMatrix Diagnostics ^*  (United States)

Author keywords

aCGH; Deletion 3'CBFB; FISH; Inv(16); Microarray

Indexed keywords

ANTINEOPLASTIC AGENT; MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CBFB GENE; CHROMOSOME 16Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE SEQUENCE; HUMAN; KARYOTYPE 46,XY; MALE; MENINX DISORDER; MULTIPLE CYCLE TREATMENT; MYH11 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS VIRIDANS INFECTION; VISUAL DISORDER; CHROMOSOME 16; GENETICS;

ADULT; CHROMOSOME DELETION; CHROMOSOME INVERSION; CHROMOSOMES, HUMAN, PAIR 16; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052808144     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.05.005     Document Type: Article

References (8)

1. Tirado C.A., Valdez F., Klesse L., et al. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genet Cytogenet 2010, 200:54-59.
2. Spencer D.V., Cavalier M.E., Kalpatthi R., Quigley D.I. Inverted and deleted chromosome 16 with deletion of 3'CBFB identified by fluorescence in situ hybridization. Cancer Genet Cytogenet 2007, 179:82-84.
3. Hung D., St Heaps L., Benson W., et al. Deletion of 3'CBFB in an inv(16)(p13.1q22) ascertained by fluorescence in situ hybridization and reverse-transcriptase polymerase chain reaction. Cancer Genet Cytogenet 2007, 172:92-94.
4. Kelly J., Foot N.J., Conneally E., et al. 3'CBFB deletion associated with inv(16) in acute myeloid leukemia. Cancer Genet Cytogenet 2005, 162:122-126.
5. Egan N., O'Reilly J., Chipper L., et al. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16. Cancer Genet Cytogenet 2004, 154:60-62.
6. Batanian J.R., Huang Y., Fallon R. Deletion of 3'-CBFB gene in association with an inversion (16)(p13q22) and a loss of the Y chromosome in a 2-year-old child with acute myelogenous leukemia-M4. Cancer Genet Cytogenet 2000, 121:216-219.
7. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer (IARC), Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
8. van Dongen J.J.M., MacIntyre E.A., Gabert J.A., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia 1999, 13:1901-1928.